基於影像的FFR診斷市場規模、佔有率和成長分析:按技術類型、應用領域、最終用戶和地區分類-2026-2033年產業預測
市場調查報告書
商品編碼
1964641

基於影像的FFR診斷市場規模、佔有率和成長分析:按技術類型、應用領域、最終用戶和地區分類-2026-2033年產業預測

Image-based FFR Diagnosis Market Size, Share, and Growth Analysis, By Technique Type (CT Angiography, MRI), By Application Area, By Technology Type, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024年全球基於影像的FFR診斷市場價值為8.118億美元,預計將從2025年的8.4995億美元成長到2033年的12.2735億美元。預測期(2026-2033年)的複合年成長率預計為4.7%。

全球基於影像的FFR診斷市場需求旺盛,其驅動力在於對非侵入性血流動力學評估的需求,旨在提高臨床決策的準確性。此方法結合了冠狀動脈CT血管攝影檢查和計算流體力學,能夠估算動脈病變處的壓力梯度,使醫師無需進行有創導管介入即可有效分診患者。這種方法顯著降低了手術風險和成本,有助於醫院更快地採用該方法,並改善患者預後。影像技術和人工智慧的進步極大地提高了診斷準確性,增強了臨床醫生的信心,並加速了臨床應用。將這些解決方案整合到現有工作流程中,並減少不必要的侵入性手術,有助於獲得保險公司的報銷支持,並為可擴展平台的開發創造機會。這一趨勢在新興市場尤為有利,因為這些市場對先進診斷成像的需求正在不斷成長。

全球基於影像的FFR診斷市場促進因素

全球基於影像的FFR診斷市場正在成長,這主要得益於臨床工作流程效率的提高以及透過與傳統影像設備無縫整合而增強的診斷信心。這種相容性實現了與導管檢查室系統的流暢資料傳輸和同步,最終最大限度地降低了手術複雜性和工作流程中斷。由於臨床醫生可以輕鬆地將這些先進技術整合到現有診療實踐中,其應用潛力正在不斷擴大。這些系統的使用者友善性及其在介入治療過程中提升決策能力的能力,正在降低臨床應用門檻,並促使各種醫療機構的需求不斷成長。

全球基於影像的FFR診斷市場限制因素

由於臨床醫生對這些創新技術的認知度和熟悉度較低,基於影像的FFR診斷的全球市場面臨著許多限制因素。這種認知不足導致醫療服務提供者和管理者猶豫不決,使他們更傾向於採用現有的侵入性方法,而非那些可能被認為存在不確定性或顛覆性的新方法。此外,由於醫療機構往往優先考慮其他項目而非技能發展的投資,教育和培訓計畫的需求也面臨進一步的挑戰。因此,知識傳播緩慢以及臨床實踐中保守的文化阻礙了這些技術的應用,限制了供應商和醫院之間的合作,並最終導致市場成長緩慢,最終回歸傳統治療路徑。

基於影像的FFR診斷的全球市場趨勢

全球基於影像的FFR診斷市場正經歷著向人工智慧增強型診斷工作流程的重大轉變,這主要得益於臨床醫生擴大採用機器學習模型來最佳化影像解讀和簡化工作流程。這一趨勢的驅動力源於對提高診斷準確性、減少操作者差異以及增強醫療團隊決策支援的需求。供應商正優先開發可解釋的人工智慧、與PACS系統的無縫整合以及先進的使用者介面,以增強臨床醫生的信心並提高易用性。隨著人工智慧能力的不斷發展,跨學科協作和工作流程客製化對於其在臨床上的廣泛應用和營運效率的提升至關重要。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

市場考察

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場吸引力指數
  • PESTEL 分析
  • 監理情勢

全球基於影像的FFR診斷市場規模:按技術類型和複合年成長率分類(2026-2033年)

  • CT血管攝影檢查
  • MRI
  • X光影像診斷
  • 其他

全球基於影像的FFR診斷市場規模:按應用和複合年成長率分類(2026-2033年)

  • 冠狀動脈疾病
  • 周邊動脈疾病
  • 結構性心臟疾病
  • 其他

全球基於影像的FFR診斷市場規模:按技術類型和複合年成長率分類(2026-2033年)

  • 軟體解決方案
  • 醫療影像設備
  • 數據分析工具
  • 其他

全球基於影像的FFR診斷市場規模:按最終用戶和複合年成長率分類(2026-2033年)

  • 醫院
  • 診斷中心
  • 研究機構
  • 其他

全球基於影像的FFR診斷市場規模及複合年成長率(2026-2033年)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 2023-2025年營收年比比較

主要企業簡介

  • HeartFlow
  • Siemens Healthineers
  • Philips Healthcare
  • Abbott Laboratories
  • GE Healthcare
  • Terumo Corporation
  • Acist Medical Systems
  • Canon Medical Systems
  • Toshiba Medical Systems
  • Biotronik
  • Medtronic
  • Cardiologs
  • Aceso Diagnostics
  • Quantib
  • Bracco Imaging
  • Fujifilm Medical
  • Stryker Corporation
  • Cardiovascular Systems Inc.
  • Optellum
  • Imbio

結論與建議

簡介目錄
Product Code: SQMIG35I2516

Global Image-Based Ffr Diagnosis Market size was valued at USD 811.8 Million in 2024 and is poised to grow from USD 849.95 Million in 2025 to USD 1227.35 Million by 2033, growing at a CAGR of 4.7% during the forecast period (2026-2033).

The global image-based FFR diagnosis market is driven by the need for noninvasive hemodynamic assessments to enhance clinical decision-making. Utilizing coronary CT angiography combined with computational fluid dynamics, this method estimates pressure gradients across arterial lesions, allowing physicians to effectively triage patients without the need for invasive catheterization. This approach significantly reduces procedural risks and costs, promoting hospital adoption and improving patient outcomes. Enhanced imaging technologies and AI advancements have markedly increased diagnostic accuracy, leading to greater clinician confidence and fostering wider acceptance in clinical practice. The integration of these solutions into established workflows, coupled with a reduction in unnecessary invasive procedures, is encouraging payers to support reimbursement, thereby creating opportunities for scalable platforms. This trend is particularly beneficial in emerging markets where the demand for advanced imaging is on the rise.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Image-Based Ffr Diagnosis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Image-Based Ffr Diagnosis Market Segments Analysis

Global image-based ffr diagnosis market is segmented by technique type, application area, technology type, end user and region. Based on technique type, the market is segmented into CT Angiography, MRI, X-ray Imaging and Others. Based on application area, the market is segmented into Coronary Artery Disease, Peripheral Artery Disease, Structural Heart Conditions and Others. Based on technology type, the market is segmented into Software Solutions, Imaging Equipment, Data Analysis Tools and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Centers, Research Institutions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Image-Based Ffr Diagnosis Market

The Global Image-Based FFR Diagnosis market is experiencing growth driven by the seamless integration of image-based systems with traditional imaging modalities, leading to enhanced clinical workflow efficiency and increased diagnostic confidence. This compatibility facilitates smooth data transfer and synchronization with catheterization lab systems, ultimately minimizing procedural complexity and workflow disruption. As clinicians find it easier to incorporate these advanced technologies into their established practices, the likelihood of adoption rises. The user-friendly nature of these systems and their ability to improve decision-making during interventions contribute to lowered barriers for clinical adoption, resulting in heightened demand across various healthcare environments.

Restraints in the Global Image-Based Ffr Diagnosis Market

The global image-based FFR diagnosis market faces significant restraints due to limited clinical awareness and familiarity with these innovative technologies. This lack of exposure can create reluctance among healthcare providers and administrators, leading them to favor established invasive methods over newer approaches, which they may view as uncertain or disruptive. The necessity for education and training programs poses additional challenges, as institutions often prioritize competing initiatives over investment in skill development. Consequently, slow dissemination of knowledge and conservative cultures within clinical practices hinder the adoption of these technologies, restrict collaboration between vendors and hospitals, and ultimately slow the market's growth into conventional care pathways.

Market Trends of the Global Image-Based Ffr Diagnosis Market

The Global Image-Based FFR Diagnosis market is witnessing a significant shift towards AI-enhanced diagnostic workflows, as clinicians embrace machine learning models to optimize image interpretation and streamline workflows. This trend is driven by the need for improved diagnostic confidence, reduction of variability among operators, and enhanced decision support for care teams. Vendors are prioritizing the development of explainable AI, seamless integration with PACS systems, and refined user interfaces to foster clinician trust and usability. As AI capabilities evolve, the focus on cross-disciplinary collaboration and customization of workflows is becoming essential for achieving widespread clinical adoption and enhancing operational efficiency.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Image-based FFR Diagnosis Market Size by Technique Type & CAGR (2026-2033)

  • Market Overview
  • CT Angiography
  • MRI
  • X-ray Imaging
  • Others

Global Image-based FFR Diagnosis Market Size by Application Area & CAGR (2026-2033)

  • Market Overview
  • Coronary Artery Disease
  • Peripheral Artery Disease
  • Structural Heart Conditions
  • Others

Global Image-based FFR Diagnosis Market Size by Technology Type & CAGR (2026-2033)

  • Market Overview
  • Software Solutions
  • Imaging Equipment
  • Data Analysis Tools
  • Others

Global Image-based FFR Diagnosis Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Diagnostic Centers
  • Research Institutions
  • Others

Global Image-based FFR Diagnosis Market Size & CAGR (2026-2033)

  • North America (Technique Type, Application Area, Technology Type, End User)
    • US
    • Canada
  • Europe (Technique Type, Application Area, Technology Type, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Technique Type, Application Area, Technology Type, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Technique Type, Application Area, Technology Type, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Technique Type, Application Area, Technology Type, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • HeartFlow
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Philips Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Acist Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Canon Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Toshiba Medical Systems
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiologs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aceso Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quantib
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bracco Imaging
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiovascular Systems Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Optellum
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Imbio
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations